Hypercoagulability, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome.

[1]  E. Balzar,et al.  Acquired antithrombin III deficiency in patients with glomerular proteinuria. , 1978, Haemostasis.

[2]  O. Egeberg.  Inherited Antithrombin Deficiency Causing Thrombophilia , 1965, Thrombosis and Haemostasis.

[3]  S. Massry,et al.  Renal vein thrombosis and the nephrotic syndrome. , 2020, Nephron.

[4]  L. Juncos,et al.  Chronic renal vein thrombosis. , 1977, The American journal of medicine.

[5]  E. Fisher,et al.  Experimental renal vein constriction. Its relation to renal lesions observed in human renal vein thrombosis and the nephrotic syndrome. , 1968, Laboratory investigation; a journal of technical methods and pathology.

[6]  D. Collen.  Identification and some properties of a new fast-reacting plasmin inhibitor in human plasma. , 1976, European journal of biochemistry.

[7]  I. Clemmensen,et al.  The primary inhibitor of plasmin in human plasma. , 1976, The Biochemical journal.

[8]  W. Kisiel,et al.  Anticoagulant properties of bovine plasma protein C following activation by thrombin. , 1977, Biochemistry.

[9]  D. Droz,et al.  Long-term prognosis of idiopathic membranous glomerulonephritis. Study of 116 untreated patients. , 1979, The American journal of medicine.

[10]  J. Rask-Madsen,et al.  Rectal electrolyte transport and mucosal permeability in ulcerative colitis and Crohn's disease. , 1973, The Journal of laboratory and clinical medicine.

[11]  A. S. Douglas,et al.  Fibrinolytic Enzyme System and Pregnancy , 1969, British medical journal.

[12]  G. Kaloyanides,et al.  Nephrotic syndrome, renal vein thrombosis and renal failure. Report of case with recovery of renal function, loss of proteinuria and dissolution of thrombus after anticoagulant therapy. , 1973, The American journal of medicine.

[13]  A. Stanson,et al.  Renal vein thrombosis in idiopathic membranous glomerulopathy and nephrotic syndrome: incidence and significance. , 1983, Kidney international.

[14]  W. Hitzig,et al.  Renal vein thrombosis and the nephrotic syndrome with complete remission. , 1963, Journal of the Mount Sinai Hospital, New York.

[15]  S. Kohl,et al.  CRYOFIBRINOGENÆMIA IN WOMEN USING ORAL CONTRACEPTIVES , 1970 .

[16]  R. Bertina,et al.  A one-year follow-up study of plasma fibrinopeptide A and beta-thromboglobulin after deep vein thrombosis and pulmonary embolism. , 1982, Thrombosis research.

[17]  R. Canfield,et al.  Measurement of fibrinopeptide A in human blood. , 1974, The Journal of clinical investigation.

[18]  J. Hopper,et al.  RENAL VEIN THROMBOSIS IN MEMBRANOUS GLOMERULONEPHROPATHY: INCIDENCE AND ASSOCIATION , 1978, Medicine.

[19]  P. W. Willis,et al.  Thrombosis of axillary and subclavian veins. , 1967, Archives of surgery.

[20]  V. Pollak,et al.  Nephrotic syndrome with renal vein thrombosis: pathogenetic importance of a plasmin inhibitor (alpha 2-antiplasmin). , 1985, Clinical nephrology.

[21]  N. Aoki,et al.  Release of arachidonic acid from human platelets. A key role for the potentiation of platelet aggregability in normal subjects as well as in those with nephrotic syndrome. , 1978, Blood.

[22]  B. Griffel,et al.  Bilateral renal vein thrombosis. Clinical and electron microscopic studies of a case with complete recovery after anticoagulant therapy. , 1966 .

[23]  Activation of blood coagulation in cancer: Trousseau's syndrome revisited , 1983 .

[24]  Y. Sakata,et al.  Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor. , 1980, The Journal of clinical investigation.

[25]  S. Niewiarowski,et al.  Laboratory identification of intravascular coagulation. The serial dilution protamine sulfate test for the detection of fibrin monomer and fibrin degradation products. , 1971, The Journal of laboratory and clinical medicine.

[26]  E. Marciniak.  Inhibitor of human blood coagulation elicited by thrombin. , 1972, The Journal of laboratory and clinical medicine.

[27]  C. Alfrey,et al.  Acquired factor IX deficiency in the nephrotic syndrome. , 1970, Annals of internal medicine.

[28]  V. Gurewich,et al.  The laboratory diagnosis of venous thromboembolic disease by measurement of fibrinogen-fibrin degradation products and fibrin monomer. , 1973, Chest.

[29]  I. Nilsson,et al.  Thrombosis and Oral Contraceptives: Possible Predisposition , 1973 .

[30]  Thomas Ml,et al.  Post-thrombotic inferior vena caval obstruction. A review of 24 patients. , 1970 .

[31]  J. Ygge.  Changes in blood coagulation and fibrinolysis during the postoperative period. , 1970, American journal of surgery.

[32]  N. Aoki,et al.  Isolation and characterization of alpha2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis. , 1976, The Journal of biological chemistry.

[33]  S. Wessler,et al.  Identity of plasma-activated factor X inhibitor with antithrombin 3 and heparin cofactor. , 1971, The Journal of biological chemistry.

[34]  K. Jørgensen,et al.  On the inhibitory effect of albumin on platelet aggregation. , 1980, Thrombosis research.

[35]  S. Massry,et al.  The clinical spectrum of renal vein thrombosis: acute and chronic. , 1980, The American journal of medicine.

[36]  J. Blainey,et al.  Urinary fibrin-fibrinogen degradation products in nephrotic syndrome. , 1975, British medical journal.

[37]  R. Rosenberg,et al.  Inhibition of human factor IXa by human antithrombin. , 1975, The Journal of biological chemistry.

[38]  R. Colman,et al.  Activation of Hageman factor in the nephrotic syndrome. , 1974, The American journal of medicine.

[39]  R. Rosenberg.  Actions and interactions of antithrombin and heparin. , 1975, The New England journal of medicine.

[40]  F. Walker.  Regulation of activated protein C by protein S. The role of phospholipid in factor Va inactivation. , 1981, The Journal of biological chemistry.

[41]  J. Griffin,et al.  Deficiency of protein C in congenital thrombotic disease. , 1981, The Journal of clinical investigation.

[42]  S. Massry,et al.  On the incidence of renal vein thrombosis in the nephrotic syndrome. , 1977, Archives of internal medicine.

[43]  E. Natelson,et al.  Factor IX deficiency in the nephrotic syndrome: studies with prothrombin complex concentrate. , 1975, The Journal of urology.

[44]  J. Luetscher,et al.  Treatment of nephrosis with cortisone. , 1950, The Journal of clinical investigation.

[45]  J. van der Meer,et al.  Fibrinopeptide A immunoreactivity in human plasma. , 1974, Thrombosis research.

[46]  C. Ludlam,et al.  NEW RAPID METHOD FOR DIAGNOSIS OF DEEP VENOUS THROMBOSIS , 1975, The Lancet.

[47]  N. Bang,et al.  Enhanced platelet function in glomerular renal disease. , 1973, The Journal of laboratory and clinical medicine.

[48]  L. Es,et al.  Acquired antithrombin III deficiency and thrombosis in the nephrotic syndrome. , 1978, The American journal of medicine.

[49]  N. Vaziri,et al.  Deficiency and urinary losses of factor XII in adult nephrotic syndrome. , 1982, Nephron.

[50]  F. A. Kyser.  Pulmonary artery thrombosis. , 1951, Quarterly bulletin. Northwestern University (Evanston, Ill.). Medical School.

[51]  G. Honig,et al.  Immunoquantitation of Hageman factor in urine and plasma of children with nephrotic syndrome. , 1980, The Journal of laboratory and clinical medicine.

[52]  E. Friedman,et al.  Recurrent renal vein thrombosis consequent to membranous glomerulonephritis. , 1978, Clinical nephrology.

[53]  R. Colman,et al.  Platelet hypersensitivity induced by cholesterol incorporation. , 1975, The Journal of clinical investigation.

[54]  M. Fagerhol,et al.  2 -Macroglobulin, 1 -antitrypsin, and antithrombin III in plasma and serum during fibrinolytic therapy with urokinase. , 1972, Scandinavian journal of clinical and laboratory investigation.

[55]  D. Kleinknecht,et al.  Coagulation Studies in 45 Cases of Nephrotic Syndrome without Uremia , 1970, Thrombosis and Haemostasis.

[56]  R. Marlar,et al.  Deficiency of protein C inhibitor in combined factor V/VIII deficiency disease. , 1980, The Journal of clinical investigation.

[57]  G. Honig,et al.  Urinary loss of clotting factors due to hereditary membranous glomerulopathy. , 1976, American journal of clinical pathology.

[58]  P. Sones,et al.  The detection of inferior vena caval thrombosis with computed tomography. , 1978, Radiology.

[59]  J. Stenflo.  A new vitamin K-dependent protein. Purification from bovine plasma and preliminary characterization. , 1976, The Journal of biological chemistry.

[60]  G. W. Daugherty,et al.  Bilateral renal-vein thrombosis and the nephrotic syndrome in adults. , 1963, Annals of internal medicine.

[61]  P. Desimone,et al.  Familial thrombosis due to antithrombin 3 deficiency. , 1974, Blood.

[62]  R. Steiner,et al.  CLINICAL ASPECTS OF RENAL VEIN THROMBOSIS1 , 1956 .

[63]  G. Remuzzi,et al.  Platelet hyperaggregability and the nephrotic syndrome. , 1979, Thrombosis research.

[64]  N. Vaziri,et al.  Changes of coagulation factors IX, VIII, VII, X, and V in nephrotic syndrome , 1980, The American journal of the medical sciences.

[65]  S. Massry,et al.  Renal vein thrombosis and nephrotic syndrome. A prospective study of 36 adult patients. , 1975, Annals of internal medicine.

[66]  M. Macleod,et al.  Fibrinolytic activity in plasma and urine in chronic renal disease , 1964, Journal of clinical pathology.

[67]  J. Petrie,et al.  Serum and Urinary Fibrin/Fibrinogen Degradation Products in Glomerulonephritis , 1971, British medical journal.

[68]  C. Forbes,et al.  Changes in blood coagulation and fibrinolysis in the nephrotic syndrome. , 1974, The Quarterly journal of medicine.

[69]  E. Stiehm,et al.  Fibrinolytic Studies in the Nephrotic Syndrome , 1971, Pediatric Research.

[70]  L. van Es,et al.  Unilateral renal vein thrombosis and nephrotic syndrome. Report of a case with protein selectivity and antithrombin III clearance studies. , 1976, The American journal of medicine.

[71]  F. Walker.  Regulation of activated protein C by a new protein. A possible function for bovine protein S. , 1980, The Journal of biological chemistry.

[72]  I. Nilsson,et al.  Antithrombin III in a clinical material , 1973 .

[73]  E. Friedman,et al.  β-thromboglobulin levels in the nephrotic syndrome , 1980 .

[74]  L. Janzon,et al.  Low vascular fibrinolytic activity in obesity. , 1975, Thrombosis research.

[75]  J. A. Rennie,et al.  Fibrinolytic activity in malignant disease. , 1975, Journal of clinical pathology.

[76]  E. N. Wardle,et al.  Study of Proteins and Fibrinolysis in Patients with Glomerulonephritis , 1970, British medical journal.

[77]  T. Addis.  Glomerular nephritis : diagnosis and treatment , 1948 .

[78]  R. Lohmann,et al.  Nephrotic Syndrome: A Hypercoagulable State , 1971 .

[79]  D. L. Ross,et al.  Anticoagulation in renal vein thrombosis. , 1978, Archives of internal medicine.

[80]  C. Esmon,et al.  A new vitamin K-dependent protein. A phospholipid-binding zymogen of a serine esterase. , 1976, The Journal of biological chemistry.

[81]  A. Fletcher,et al.  Association between oral contraceptive use and thromboembolism: a new approach to itsinvestigation based on plasma fibrinogen chromatography. , 1975, American journal of obstetrics and gynecology.

[82]  V. P. Butler,et al.  The generation of fibrinopeptide A in clinical blood samples: evidence for thrombin activity. , 1976, The Journal of clinical investigation.

[83]  E. Pinori,et al.  Comprehensive study of haemostasis in nephrotic syndrome. , 1983, Nephron.

[84]  G. Honig,et al.  Deficiency of Hageman factor (factor XII) in patients with the nephrotic syndrome. , 1971, The Journal of pediatrics.

[85]  L. Goodnough,et al.  Urinary excretion of Hageman factor (factor XII) and the presence of nonfunctional Hageman factor in the nephrotic syndrome. , 1981, The American journal of medicine.

[86]  R. Colman,et al.  Soluble fibrin complexes in coronary disease. , 1976, Thrombosis research.

[87]  J. Toohey,et al.  Acquired deficiency and urinary excretion of antithrombin III in nephrotic syndrome. , 1984, Archives of internal medicine.

[88]  L. Weilemann,et al.  Ultrasonic demonstration of renal vein thrombosis. , 1981, Radiology.

[89]  R. Colman,et al.  Cyclic AMP metabolism in cholesterol-rich platelets. , 1977, The Journal of biological chemistry.

[90]  H. Johnsson,et al.  Fibrinopeptide a (FPA) in patients with acute myocardial infarction. , 1979, Thrombosis research.

[91]  J. White,et al.  Vascular Complications in Nephrotic Syndrome: Relationship to Steroid Therapy and Accelerated Thromboplastin Generation , 1970, British medical journal.

[92]  K. Laake,et al.  Progressive inactivation of purified factor VII by heparin and antithrombin III. , 1974, Thrombosis research.

[93]  C. Esmon,et al.  Recurrent venous thromboembolism in patients with a partial deficiency of protein S. , 1984, The New England journal of medicine.

[94]  A. Fletcher,et al.  Platelet function studies before and after operation and the effect of postoperative thrombosis. , 1974, The Journal of laboratory and clinical medicine.

[95]  J. Hoak,et al.  Urinary plasminogen and chronic glomerulonephritis. , 1973, American journal of clinical pathology.

[96]  D. Handley,et al.  Factor-IX deficiency in the nephrotic syndrome. , 1967, Lancet.

[97]  N. Gootman,et al.  PULMONARY ARTERY THROMBOSIS. A COMPLICATION OCCURRING WITH PREDNISONE AND CHLOROTHIAZIDE THERAPY IN TWO NEPHROTIC PATIENTS. , 1964, Pediatrics.

[98]  W. Kisiel,et al.  Proteolytic activation of protein C from bovine plasma. , 1976, Biochemistry.

[99]  Joy Tkachuck,et al.  Plasminogen and antithrombin III deficiencies in the childhood nephrotic syndrome associated with plasminogenuria and antithrombinuria. , 1980, The Journal of pediatrics.

[100]  W. Kisiel.  Human Plasma Protein C: ISOLATION, CHARACTERIZATION, AND MECHANISM OF ACTIVATION BY α-THROMBIN , 1979 .

[101]  J. T. ten Cate,et al.  Acquired factor XII Deficiency in a patient with nephrotic syndrome. , 2009, Acta medica Scandinavica.

[102]  J. Hirsh.  Blood tests for the diagnosis of venous and arterial thrombosis , 1981 .

[103]  J. Steurer,et al.  Platelet aggregation and beta-thromboglobulin levels in nephrotic patients with and without thrombosis. , 1981, Clinical nephrology.

[104]  A. Y. Chen,et al.  Fibrinogen metabolism and distribution in patients with the nephrotic syndrome. , 1967, The Journal of laboratory and clinical medicine.

[105]  W. Bennett.  Renal Vein Thrombosis in Nephrotic Syndrome , 1975 .

[106]  J. Amiral,et al.  Development and Performance Characteristics of a Competitive Enzyme Immunoassay for Fibrinopeptide A , 1984, Seminars in thrombosis and hemostasis.

[107]  V. Pollak,et al.  RENAL VEIN THROMBOSIS IN THE ADULT: A CLINICAL AND PATHOLOGIC STUDY BASED ON RENAL BIOPSIES , 1968, Medicine.

[108]  C. Forbes,et al.  Plasma Fibrinopeptide A and Beta-Thromboglobulin in Pre-Eclampsia and Pregnancy Hypertension , 1982, Thrombosis and Haemostasis.

[109]  R. Colman,et al.  Platelet function in hyperlipoproteinemia. , 1974, The New England journal of medicine.

[110]  J. Hirsh,et al.  Relevance of preoperative and postoperative blood tests to postoperative leg-vein thrombosis. , 1973, Lancet.